Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CEFUROXIMA HELM 50 MG POLVO PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/CEFUROXIMA HELM 50 MG POLVO PARA SOLUCION INYECTABLE

Approved

STANDARD

CEFUROXIMA HELM 50 MG POLVO PARA SOLUCION INYECTABLE

Helm Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 10, 2021
Approval ID: b6f38f4492d0b674
Company: Helm Ag
Type: Standard

Approval Details

Approval Id: b6f38f4492d0b674
Drug Cima Aemps Name: CEFUROXIMA HELM 50 MG POLVO PARA SOLUCION INYECTABLE
Register Number: 85960
Holder Company Name: Helm Ag
Marketing Company Name: Helm Ag
Authorization Date: 2021-05-10
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 50 mg
Route Of Administration: USO INTRACAMERAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Helm Ag

Active Ingredients

CEFUROXIMA SODICA

52,6 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 10, 2021

Approval ID

b6f38f4492d0b674

Type

Standard

Back to CIMA-AEMPS Approvals